Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Selective cytotoxicity for transformed 3T3 cells

Abstract

THE therapeutic usefulness of many anti-cancer agents depends on their selective toxicity for cells in the S (DNA synthesising) phase of the cell cycle1. Thus, rapidly proliferating cancer cells are more effectively killed by these agents than are normal cell populations, which have a lower proportion of cells in S. In theory, it should be possible to reduce the toxicity of such agents significantly by further slowing the entry of normal cells into S. We have tested this possibility in vitro by exploiting the ability of cyclic AMP derivatives to inhibit the entry into S phase of 3T3 cells, but not their malignant counterparts, transformed by SV40.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Valeriate, F., and van Putten, L., Cancer Res., 2619–2630 (1975).

  2. Johnson, G. S., and Pastan, I., J. natn. Cancer Inst., 48, 1377–1387 (1972).

    CAS  Google Scholar 

  3. Rozengurt, E., and Pardee, A. B., J. cell. Physiol., 80, 273–279 (1972).

    Article  CAS  Google Scholar 

  4. Froehlich, J. E., and Rachmeler, M., J. Cell Biol., 50, 249–257 (1974).

    Article  Google Scholar 

  5. Paul, D., Nature new Biol., 240, 179–181 (1972).

    Article  CAS  Google Scholar 

  6. Smets, L. A., Nature new Biol., 239, 123–124 (1972).

    Article  CAS  Google Scholar 

  7. Chasim, M., Harris, D. N., Phillips, M. B., and Hess, S. M., Biochem. Pharmac., 21, 2443–2450 (1972).

    Article  Google Scholar 

  8. Stoker, M. G. P., Proc. R. Soc., B 181, 1–17 (1972).

    ADS  CAS  Google Scholar 

  9. Pardee, A. B., Proc. natn. Acad. Sci. U.S.A., 71, 1286–1290 (1974).

    Article  ADS  CAS  Google Scholar 

  10. Toniolo, D., and Basilico, C., Cell, 4, 255–262 (1975).

    Article  CAS  Google Scholar 

  11. Vogel, A., and Pollack, R., J. cell Physiol., 25, 151–162 (1975).

    Article  Google Scholar 

  12. Burstin, S. J., and Basilico, C., Proc. natn. Acad. Sci. U.S.A., 72, 2540–2544 (1975).

    Article  ADS  CAS  Google Scholar 

  13. Bourne, H., Coffino, P., Melmon, K., Tomkins, G., and Weinstein, Y., Adv. cyclic Nucleotide Res., 5, 771–786 (1975).

    CAS  PubMed  Google Scholar 

  14. Pardee, A. B., and James, L., Proc. natn. Acad. Sci. U.S.A., 72, 4994–4998 (1975).

    Article  ADS  CAS  Google Scholar 

  15. O'Neill, F. J. O., Cancer Res., 35, 1311–1315 (1975).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

ROZENGURT, E., Po, C. Selective cytotoxicity for transformed 3T3 cells. Nature 261, 701–702 (1976). https://doi.org/10.1038/261701a0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/261701a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing